The tweet was deleted by the author.
But we saved everything 🙂.
Upstream Bio, Inc. will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, set for June 10 in Miami.
The company is slated for a fireside chat on Wednesday, June 10, at 10:40 a.m. ET. Upstream Bio's presence at this key industry event signals continued engagement with major healthcare investors and stakeholders.
Upstream Bio, Inc. recently released Phase 2 VIBRANT trial data on verekitug for CRSwNP with comorbid asthma at ATS2026. The company has maintained a focus on respiratory and inflammatory conditions in its pipeline. Its participation in industry events highlights continued visibility among healthcare peers and investors.